Acceptability of COVID‐19 vaccination in Chinese children aged 3–7 years with bronchopulmonary dysplasia
Pediatric Pulmonology · 2023
DOI: 10.1002/ppul.26336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, 2023. Verfasst von Dan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, COVID-19, COVID-19 Vaccines, East Asian People. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objectives
To describe the status of coronavirus disease 2019 (COVID‐19) vaccination with inactivated vaccines BBIBP‐CorV and CoronaVac in Chinese children aged 3–7 years with bronchopulmonary dysplasia (BPD), and explore factors influencing vaccination and reasons for nonvaccination.
Methods
This cross‐sectional study involving parents of 397 BPD children aged 3–7 years was conducted through WeChat or follow‐up telephone interviews using a standardized questionnaire form. Factors influencing COVID‐19 vaccination were explored by using modified Poisson regression models.
Results
The overall COVID‐19 vaccination rate was 69.0% (95% confidence interval: 64.3%–73.4%). COVID‐19 vaccination was less likely to be accepted in children whose mothers had a relatively high educational background (university and above), who lived in urban areas and had a low birth weight (300,000 CNY (41,400 USD) were more likely to accept vaccination. Adverse reactions occurred in 13/274 children (4.7%) within 10 days after vaccination. With respect to reasons of not accepting COVID‐19 vaccination, 95 parents (77.2%) worried about the adverse reactions, and 17 parents (13.8%) refused vaccination on the excuse of not being convenient to go to the vaccination station or not knowing where to get the vaccines.
Conclusions
The COVID‐19 vaccination rate in BPD children aged 3–7 years needs to be further improved in China. Continuous efforts are required to monitor postvaccination adverse reactions in BPD children, and make vaccination more convenient and accessible.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
- Department of Newborn Care Center, Senior Department of Pediatrics, The Seventh Medical Center of PLA General Hospital, Beijing, China.
- National Engineering Laboratory for Birth Defects Prevention and Control of Key Technology, Beijing, China.
- Beijing Key Laboratory of Pediatric Organ Failure, Beijing, China.
- State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
- Faculty of Pediatrics, The Chinese PLA General Hospital, Beijing, China.
ORCID-Profile: Li Li
Zitieren
APA
Wang, D., Li, L., Cao, J., Hu, S., Liu, C., Feng, Z., & Li, Q. (2023). Acceptability of COVID‐19 vaccination in Chinese children aged 3–7 years with bronchopulmonary dysplasia. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26336
Vancouver
Wang D, Li L, Cao J, Hu S, Liu C, Feng Z, et al. Acceptability of COVID‐19 vaccination in Chinese children aged 3–7 years with bronchopulmonary dysplasia. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26336
BibTeX
@article{Wang2023,
author = {Wang, Dan and Li, Li and Cao, Jingke and Hu, Siqi and Liu, Changgen and Feng, Zhichun and Li, Qiuping},
title = {Acceptability of COVID‐19 vaccination in Chinese children aged 3–7 years with bronchopulmonary dysplasia},
journal = {Pediatric Pulmonology},
year = {2023},
doi = {10.1002/ppul.26336}
}
EUVIMED